NasdaqGM - Nasdaq Real Time Price USD
Janux Therapeutics, Inc. (JANX)
25.69
-0.52
(-1.98%)
As of 12:19:20 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AVALON VENTURES XI, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale | Oct 18, 2024 | -- |
| CAMPBELL DAVID ALAN Chief Executive Officer | Sale | Jan 7, 2025 | 293,054 |
| DIRAIMONDO THOMAS PH.D. Officer | Stock Award(Grant) | Jan 2, 2025 | 129,719 |
| DOBEK MARIA Officer | Stock Award(Grant) | Jan 2, 2025 | 14,001 |
| DOYLE JANEEN NOEL Officer | Stock Award(Grant) | Jun 2, 2025 | 44,000 |
| MCIVER ZACHARIAH Officer | Stock Award(Grant) | Jan 2, 2025 | 26,000 |
| MEYER ANDREW HOLLMAN Officer | Conversion of Exercise of derivative security | May 1, 2025 | 82,139 |
| RA CAPITAL MANAGEMENT, L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 7, 2025 | -- |
| ROBINSON BYRON J.D., PH.D. Officer | Stock Award(Grant) | Jan 2, 2025 | 28,000 |
| WINTER CHARLES M Chief Technology Officer | Stock Award(Grant) | Jan 2, 2025 | 77,288 |
Related Tickers
EWTX Edgewise Therapeutics, Inc.
15.02
-1.44%
CGEM Cullinan Therapeutics, Inc.
8.91
-1.87%
ANAB AnaptysBio, Inc.
22.83
-3.67%
SRRK Scholar Rock Holding Corporation
33.75
-1.40%
AKRO Akero Therapeutics, Inc.
53.74
-0.99%
NUVL Nuvalent, Inc.
75.87
-2.76%
RGNX REGENXBIO Inc.
9.39
-2.34%
RNA Avidity Biosciences, Inc.
31.97
-11.80%
APGE Apogee Therapeutics, Inc.
39.97
-2.47%
TYRA Tyra Biosciences, Inc.
10.23
-3.03%